Showing results (1341-1350 of 5,275) with videos related to
Sort By:
Pageof 528
Oncology|February 17, 2009
Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastomaM Glas, T Hundsberger, M Stuplich, et al.Oncology|January 1, 1978
Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experimentsW Rella, B ChaputOncology|November 6, 2010
Trimodal therapy for inflammatory breast cancer: a surgeon's perspectiveBenjamin D Li, Mark A Sicard, Fred Ampil, et al.Oncology|March 31, 2011
A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancerDeborah Citrin, Kevin Camphausen, Bradford J Wood, et al.Oncology|April 14, 2011
A six-week course of bacillus Calmette-Guérin prophylaxis is insufficient to prevent tumor recurrence in nonmuscle invasive bladder cancer with strong-positive expression of p53Jong Jin Oh, Sang Hyun Ji, Don Kyoung Choi, et al.Oncology|March 25, 2011
Clinical significance of pretreatment C-reactive protein in patients with advanced nonsquamous, non-small cell lung cancer who received gefitinibKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.Oncology|June 24, 2019
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid TumorsDavid Hong, Drew Rasco, Michael Veeder, et al.Oncology|September 1, 1997
Lung cancer: review of the ECOG experience. Eastern Cooperative Oncology GroupJ H Schiller, J Cleary, D JohnsonOncology|September 1, 1997
Serum-soluble IL-2 receptor and IL-6 levels in patients with melanomaM D Boyano, M D García-Vázquez, J Gardeazabal, et al.Oncology|January 15, 1998
Long-term follow-up and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institutionJ Aparicio, B Munárriz, M Pastor, et al.Pageof 528